# PRESS RELEASE 2018

- # [Ferring announces recipients of 2018-19 Innovation Grants](/content/ferring-announces-recipients-of-2018-19-innovation-grants/index.html)

Ferring Pharmaceuticals today announced the recipients of the 2018-19 Ferring Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in San Diego.

- # [Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer](/content/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer/index.html)

Ferring Pharmaceuticals today announced that Michel Pettigrew, President of the Executive Board and Chief Operating Officer.

- # [Ferring Pharmaceuticals and Evotec AG form strategic research alliance in reproductive medicine and women’s health](/content/ferring-pharmaceuticals-and-evotec-ag-form-strategic-research-alliance-in-reproductive-medicine-and-womens-health/index.html)

Ferring Pharmaceuticals and Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced a strategic research alliance.

- # [Ferring and Celmatix launch ambitious genomics collaboration to advance care in reproductive medicine and women’s health](/content/ferring-and-celmatix-launch-ambitious-genomics-collaboration-to-advance-care-in-reproductive-medicine-and-womens-health/index.html)

Ferring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering new insights into ovarian health.

- # [New analysis of Rekovelle® data further supports use of AMH to personalise fertility treatment](/content/new-analysis-of-rekovelle-data-further-supports-use-of-amh-to-personalise-fertility-treatment/index.html)

Ferring Pharmaceuticals announced today a new analysis* of data from the Phase 3 ESTHER-1 trial.

- # [Ferring’s heat-stable carbetocin could save thousands of women’s lives by preventing excessive bleeding after childbirth](/content/ferrings-heat-stable-carbetocin-could-save-thousands-of-womens-lives-by-preventing-excessive-bleeding-after-childbirth/index.html)

Ferring Pharmaceuticals today announced new data demonstrating that its heat-stable formulation of carbetocin could significantly improve maternal health.

- # [Ferring signs global agreement to commercialise novel gene therapy for bladder cancer patients](/content/ferring-signs-global-agreement-to-commercialise-novel-gene-therapy-for-bladder-cancer-patients/index.html)

Ferring Pharmaceuticals today announced the signing of an agreement giving the company the option to secure global rights for a novel gene therapy.

- # [Ferring acquires innovative biotechnology company and microbiome pioneer Rebiotix Inc.](/content/ferring-acquires-innovative-biotechnology-company-and-microbiome-pioneer-rebiotix-inc/index.html)

Ferring Pharmaceuticals and Rebiotix Inc. today announce that they have agreed to the acquisition of Rebiotix by Ferring.

- # [Nocturia: the most common cause of a poor night’s sleep, say experts on World Sleep Day](/content/nocturia-the-most-common-cause-of-a-poor-nights-sleep-say-experts-on-world-sleep-day/index.html)

On World Sleep Day, scientists are highlighting the number one reason that people are waking up at night – nocturia.

- # [Ferring announces positive outcome of European Decentralised Procedure (DCP) for Testavan®, a treatment for men with hypogonadism](/content/ferring-announces-positive-outcome-of-european-decentralised-procedure-dcp-for-testavan-a-treatment-for-men-with-hypogonadism/index.html)

Ferring Pharmaceuticals today announced the positive outcome of the European Decentralised Procedure (DCP) for Testavan®.